Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression1This work was supported by a grant from the Crohn's and Colitis Foundation of America.1-Reference-Cited by-同舟云学术

Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression1This work was supported by a grant from the Crohn's and Colitis Foundation of America.1

Published:1998-06 Issue:1-2 Volume:141 Page:179-186
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Dunphy Jillian L,Taylor Russel G,Fuller Peter J

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference32 articles.

1. Systemic factors are trophic in bypassed rat small intestine in the absence of luminal contents;Albert;Gut,1990

2. The hormonal pattern of intestinal adaptation; a major role for enteroglucagon;Bloom;Scand. J. Gastroenterol.,1983

3. Mechanisms of intestinal adaptation;Bristol;Pediatr. Surg. Int.,1988

4. Glucagon glucagon-like peptide I receptor chimeras reveal domains that determine specificity of glucagon binding;Buggy;J. Biol. Chem.,1995

5. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.;Bullock;Endocrinology,1996

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review;Physiology & Behavior;2024-09

2. Therapeutic Effects of Semaglutide on Nonalcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus and Obesity: An Open-Label Controlled Trial;Diseases;2024-08-17

3. Unraveling the Puzzle of Therapeutic Peptides: A Promising Frontier in Huntington’s Disease Treatment;Journal of Medicinal Chemistry;2024-01-11

4. Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation;Kidney International;2024-01

5. Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions;Gastroenterology Report;2023-12-22